Real Clear Policy: Strangling Generic Drugs is the Wrong Path to Lower Prices

Lowering drug prices is a public policy objective that everyone can agree on. About 18 million patients can’t afford their prescribed medications, according to a recent poll, including nearly 1 in 5 members of the poorest households. Unfortunately, Congress’ plan to control pharmaceutical prices consists of half-baked proposals that would do serious harm to consumers, including the decimation of the generic drug industry that works to keep prices down.

You can read this commentary in Real Clear Policy

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin